SMAD4 and lung carcinoma: Reexpression of Smad4 significantly attenuated SPK cell migration and invasion in a transwell study (Fig. 2e, f), while knocking down Smad4 enhanced invasion in human lung cancer cells (Supplementary Fig. 2f).